Guru Ownership Trend
Guru Analysis for Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.77 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.07 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 716.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Eledon Pharmaceuticals, Inc. (ELDN)
Major holders include Cliff Asness ($2.29 M), Renaissance Technologies (RenTech) ($791,546). According to the latest reported data, 2 tracked investment managers collectively hold approximately 781,928 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.07 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited ELDN. The total reported sell value was $3.37 M.
Yes, 0 managers opened new positions in ELDN, and 2 increased their existing holdings. The total reported buy value was $2.3 M.